Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash from Investing Activities (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Cash from Investing Activities readings, the most recent being $9.7 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 182.55% to $9.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.3 million, a 62.54% decrease, with the full-year FY2025 number at $13.3 million, down 62.54% from a year prior.
  • Cash from Investing Activities hit $9.7 million in Q4 2025 for Treace Medical Concepts, up from $8.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $22.4 million in Q2 2024 to a low of -$80.5 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$785000.0 (2021), compared with a mean of -$5.6 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 7012.44% in 2022 and later soared 315.23% in 2024.
  • Treace Medical Concepts' Cash from Investing Activities stood at -$900000.0 in 2021, then plummeted by 7012.44% to -$64.0 million in 2022, then soared by 107.82% to $5.0 million in 2023, then tumbled by 31.68% to $3.4 million in 2024, then surged by 182.55% to $9.7 million in 2025.
  • The last three reported values for Cash from Investing Activities were $9.7 million (Q4 2025), $8.7 million (Q3 2025), and -$3.3 million (Q2 2025) per Business Quant data.